Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Restructuring watch

Restructuring watch

Date Company Staff cuts Cash Years cash pre-cut Cash date Oper loss for 9 mos ended 9/30
10/2/07 Aeterna Zentaris (TSX:AEZ; NASDAQ:AEZS) Not disclosed $47.6 1.55 9/30/07 $23.0
Seeking to divest non-core assets to

Read the full 363 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE